Free Trial

Spire Healthcare Group (SPI) Competitors

Spire Healthcare Group logo
GBX 248 +0.50 (+0.20%)
As of 11:58 AM Eastern

SPI vs. UDG, UPR, MGP, SBI, and OHGR

Should you buy Spire Healthcare Group stock or one of its competitors? Spire Healthcare Group's main competitors and comparable companies include UDG Healthcare (UDG), Uniphar (UPR), Medica Group (MGP), Sourcebio International (SBI), and One Health Group (OHGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Spire Healthcare Group compare to UDG Healthcare?

Spire Healthcare Group (LON:SPI) and UDG Healthcare (LON:UDG) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

Spire Healthcare Group has higher revenue and earnings than UDG Healthcare. Spire Healthcare Group is trading at a lower price-to-earnings ratio than UDG Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spire Healthcare Group£1.58B0.63£28.15M-£0.50N/A
UDG Healthcare£1.25B0.00N/A£25.40N/A

Spire Healthcare Group pays an annual dividend of GBX 1.50 per share and has a dividend yield of 0.6%. UDG Healthcare pays an annual dividend of GBX 0.17 per share. Spire Healthcare Group pays out -300.0% of its earnings in the form of a dividend. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Spire Healthcare Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

UDG Healthcare has a net margin of 0.00% compared to Spire Healthcare Group's net margin of -0.12%. UDG Healthcare's return on equity of 0.00% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Spire Healthcare Group-0.12% -0.26% 3.73%
UDG Healthcare N/A N/A N/A

22.1% of Spire Healthcare Group shares are owned by institutional investors. 39.3% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Spire Healthcare Group had 2 more articles in the media than UDG Healthcare. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for UDG Healthcare. Spire Healthcare Group's average media sentiment score of 0.24 beat UDG Healthcare's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the media.

Company Overall Sentiment
Spire Healthcare Group Neutral
UDG Healthcare Neutral

Spire Healthcare Group currently has a consensus target price of GBX 247.50, indicating a potential downside of 0.20%. Given UDG Healthcare's higher probable upside, analysts plainly believe UDG Healthcare is more favorable than Spire Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spire Healthcare Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
UDG Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Spire Healthcare Group beats UDG Healthcare on 10 of the 15 factors compared between the two stocks.

How does Spire Healthcare Group compare to Uniphar?

Uniphar (LON:UPR) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

38.8% of Uniphar shares are owned by institutional investors. Comparatively, 22.1% of Spire Healthcare Group shares are owned by institutional investors. 7.9% of Uniphar shares are owned by company insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Uniphar pays an annual dividend of GBX 2.02 per share and has a dividend yield of 0.6%. Spire Healthcare Group pays an annual dividend of GBX 1.50 per share and has a dividend yield of 0.6%. Uniphar pays out 9.8% of its earnings in the form of a dividend. Spire Healthcare Group pays out -300.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Spire Healthcare Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Spire Healthcare Group has a consensus price target of GBX 247.50, indicating a potential downside of 0.20%. Given Spire Healthcare Group's stronger consensus rating and higher possible upside, analysts clearly believe Spire Healthcare Group is more favorable than Uniphar.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Uniphar
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Uniphar has a net margin of 1.69% compared to Spire Healthcare Group's net margin of -0.12%. Uniphar's return on equity of 12.80% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Uniphar1.69% 12.80% 3.76%
Spire Healthcare Group -0.12%-0.26%3.73%

Uniphar has a beta of 1.129, suggesting that its share price is 13% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.875, suggesting that its share price is 13% less volatile than the broader market.

In the previous week, Spire Healthcare Group had 2 more articles in the media than Uniphar. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Uniphar. Spire Healthcare Group's average media sentiment score of 0.24 beat Uniphar's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Uniphar Neutral
Spire Healthcare Group Neutral

Uniphar has higher revenue and earnings than Spire Healthcare Group. Spire Healthcare Group is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uniphar£3.18B0.29£51.04M£20.6017.38
Spire Healthcare Group£1.58B0.63£28.15M-£0.50N/A

Summary

Uniphar and Spire Healthcare Group tied by winning 9 of the 18 factors compared between the two stocks.

How does Spire Healthcare Group compare to Medica Group?

Medica Group (LON:MGP) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

In the previous week, Spire Healthcare Group had 2 more articles in the media than Medica Group. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Medica Group. Spire Healthcare Group's average media sentiment score of 0.24 beat Medica Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Medica Group Neutral
Spire Healthcare Group Neutral

88.4% of Medica Group shares are owned by institutional investors. Comparatively, 22.1% of Spire Healthcare Group shares are owned by institutional investors. 2.9% of Medica Group shares are owned by company insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Spire Healthcare Group has higher revenue and earnings than Medica Group. Spire Healthcare Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medica Group£76.98M0.00£7.20M£0.06N/A
Spire Healthcare Group£1.58B0.63£28.15M-£0.50N/A

Spire Healthcare Group has a consensus target price of GBX 247.50, indicating a potential downside of 0.20%. Given Medica Group's higher probable upside, equities research analysts plainly believe Medica Group is more favorable than Spire Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medica Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Medica Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.875, suggesting that its share price is 13% less volatile than the broader market.

Medica Group has a net margin of 9.35% compared to Spire Healthcare Group's net margin of -0.12%. Medica Group's return on equity of 12.42% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medica Group9.35% 12.42% 6.62%
Spire Healthcare Group -0.12%-0.26%3.73%

Medica Group pays an annual dividend of GBX 3 per share. Spire Healthcare Group pays an annual dividend of GBX 1.50 per share and has a dividend yield of 0.6%. Medica Group pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Spire Healthcare Group pays out -300.0% of its earnings in the form of a dividend. Spire Healthcare Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Spire Healthcare Group beats Medica Group on 9 of the 17 factors compared between the two stocks.

How does Spire Healthcare Group compare to Sourcebio International?

Spire Healthcare Group (LON:SPI) and Sourcebio International (LON:SBI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Spire Healthcare Group presently has a consensus price target of GBX 247.50, suggesting a potential downside of 0.20%. Given Sourcebio International's higher possible upside, analysts clearly believe Sourcebio International is more favorable than Spire Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spire Healthcare Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Sourcebio International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

22.1% of Spire Healthcare Group shares are held by institutional investors. 39.3% of Spire Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Spire Healthcare Group has higher revenue and earnings than Sourcebio International. Spire Healthcare Group is trading at a lower price-to-earnings ratio than Sourcebio International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spire Healthcare Group£1.58B0.63£28.15M-£0.50N/A
Sourcebio International£75.61M0.00N/A£0.09N/A

Sourcebio International has a net margin of 0.00% compared to Spire Healthcare Group's net margin of -0.12%. Sourcebio International's return on equity of 0.00% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Spire Healthcare Group-0.12% -0.26% 3.73%
Sourcebio International N/A N/A N/A

In the previous week, Spire Healthcare Group had 2 more articles in the media than Sourcebio International. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Sourcebio International. Spire Healthcare Group's average media sentiment score of 0.24 beat Sourcebio International's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the media.

Company Overall Sentiment
Spire Healthcare Group Neutral
Sourcebio International Neutral

Summary

Spire Healthcare Group beats Sourcebio International on 8 of the 13 factors compared between the two stocks.

How does Spire Healthcare Group compare to One Health Group?

Spire Healthcare Group (LON:SPI) and One Health Group (LON:OHGR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Spire Healthcare Group currently has a consensus target price of GBX 247.50, suggesting a potential downside of 0.20%. Given Spire Healthcare Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Spire Healthcare Group is more favorable than One Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spire Healthcare Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
One Health Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Spire Healthcare Group pays an annual dividend of GBX 1.50 per share and has a dividend yield of 0.6%. One Health Group pays an annual dividend of GBX 6.23 per share and has a dividend yield of 2.1%. Spire Healthcare Group pays out -300.0% of its earnings in the form of a dividend. One Health Group pays out 41.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

22.1% of Spire Healthcare Group shares are owned by institutional investors. Comparatively, 11.0% of One Health Group shares are owned by institutional investors. 39.3% of Spire Healthcare Group shares are owned by insiders. Comparatively, 46.8% of One Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

One Health Group has a net margin of 0.00% compared to Spire Healthcare Group's net margin of -0.12%. One Health Group's return on equity of 0.00% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Spire Healthcare Group-0.12% -0.26% 3.73%
One Health Group N/A N/A N/A

In the previous week, Spire Healthcare Group had 2 more articles in the media than One Health Group. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for One Health Group. Spire Healthcare Group's average media sentiment score of 0.24 beat One Health Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the media.

Company Overall Sentiment
Spire Healthcare Group Neutral
One Health Group Neutral

Spire Healthcare Group has higher revenue and earnings than One Health Group. Spire Healthcare Group is trading at a lower price-to-earnings ratio than One Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spire Healthcare Group£1.58B0.63£28.15M-£0.50N/A
One Health Group£31.59M1.31N/A£14.9820.28

Summary

Spire Healthcare Group beats One Health Group on 9 of the 16 factors compared between the two stocks.

Get Spire Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPI vs. The Competition

MetricSpire Healthcare GroupHealthcare Providers & Services IndustryHealthcare SectorLON Exchange
Market Cap£993.48M£10.87B£7.88B£2.84B
Dividend Yield0.61%2.54%2.47%5.11%
P/E Ratio-496.0030.3233.3323.37
Price / Sales0.632.028.125.05
Price / Cash9.1223.2821.0220.23
Price / Book1.363.984.802.51
Net Income£28.15M£332.46M£3.52B£5.88B
7 Day Performance0.20%-3.16%-4.56%-0.01%
1 Month PerformanceN/A-0.24%-2.78%-2.15%
1 Year Performance11.21%21.17%0.12%7.21%

Spire Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPI
Spire Healthcare Group
0.447 of 5 stars
GBX 248
+0.2%
GBX 247.50
-0.2%
+11.0%£993.48M£1.58BN/A420
UDG
UDG Healthcare
N/AN/AN/AN/A£2.72B£1.25B42.489,000
UPR
Uniphar
N/AGBX 356
-1.1%
N/A+6.5%£924.08M£3.18B17.283,000
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools


This page (LON:SPI) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners